34.10
34.10 (0%)
As of Feb 14, 2025
Surmodics Inc [SRDX]
Source:
Company Overview
Surmodics, Inc. is a leading provider of performance coating technologies for intravascular medical devices and chemical and biological components for in vitro diagnostic (“IVD”) immunoassay tests and microarrays.
| Country | United States |
| Headquarters | eden prairie, minnesota |
| Phone Number | 9525007000 |
| Industry | manufacturing |
| CEO | Gary R. Maharaj |
| Website | www.surmodics.com |
Financial Year:
Financial Overview (Dollars in Millions)
| Revenue | $29.9 |
| Operating Profit | $-2.5 |
| Net Income | $-3.7 |
| Net Cash | $-6 |
Profit Ratios
| Gross Margin | $29.9 |
| Operating Margin | -8.3 |
| Profit as % of Revenues | -819.6% |
| Profit as % of Assets | -2.1% |
| Profit as % of Stockholder Equity | -3.3% |
Management Effectiveness
| Return on Equity | -3.3% |
| Return on Assets | -2.2% |
| Turnover Ratio | 17.5% |
| EBITA | $-1.6 |
Balance Sheet and Cash Flow Measures
| Total Assets | $163.7 |
| Total Liabilities | $52 |
| Operating Cash Flow | $-7.9 |
| Investing Cash Flow | $3.7 |
| Financing Cash Flow | $-1.2 |
